17:14 EDT Moleculin Biotech (MBRX) files to sell 64.86M shares of common stock for holders
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MBRX:
- Moleculin Biotech’s Strategic Expansion and Promising Data Support Buy Rating
- Moleculin Biotech Expands Global Phase 2B/3 Trial
- Moleculin Biotech accelerates recruitment in Phase 3 MIRACLE trial
- Moleculin Biotech Releases New Corporate Presentation
- Moleculin Biotech Begins Phase 2B/3 MIRACLE Trial Enrollment